Dunlop A. Sinclair
SEC insider (Form 3/4/5 filer). CIK 0001721108. Director at Apellis Pharmaceuticals, Inc. (APLS). 17 reported Form 4/5 transactions since Sep 2024; latest on May 14, 2026. Located in WALTHAM, MA.
Companies Dunlop A. Sinclair has filed insider reports for
- Apellis Pharmaceuticals, Inc. (APLS): Director
Dunlop A. Sinclair
CIK: 0001721108
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Apellis Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect5.7K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect3.5K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect8K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
Tender OfferDirect161.6K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect3.1K shares- - Jan 1, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect8K shares- - Oct 10, 2025APLS
Apellis Pharmaceuticals, Inc.
OtherIndirect3.8K shares- - Oct 10, 2025APLS
Apellis Pharmaceuticals, Inc.
SaleIndirect31.1K shares at avg. $23.72$738K - Sep 30, 2025APLS
Apellis Pharmaceuticals, Inc.
OtherIndirect3.8K shares- - Sep 30, 2025APLS
Apellis Pharmaceuticals, Inc.
SaleIndirect31.1K shares at avg. $22.58$702K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 5,744 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 3,544 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 7,961 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Tender Offer | 161,567 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 3,062 | - | $0 | Direct |
| Jan 1, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 7,961 | - | $0 | Direct |
| Oct 10, 2025 | APLS Apellis Pharmaceuticals, Inc. | Other | 3,837 | - | - | Indirect |
| Oct 10, 2025 | APLS Apellis Pharmaceuticals, Inc. | Sale | 31,092 | $23.72 | $737,536 | Indirect |
| Sep 30, 2025 | APLS Apellis Pharmaceuticals, Inc. | Other | 3,837 | - | - | Indirect |
| Sep 30, 2025 | APLS Apellis Pharmaceuticals, Inc. | Sale | 31,092 | $22.58 | $702,057 | Indirect |
1-10 of 17 transactions